161 related articles for article (PubMed ID: 36000376)
1. [
Wang M; Zhou ZG; Du KP; Li S; Li YD; Gao F; Gao JB
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2458-2464. PubMed ID: 36000376
[No Abstract] [Full Text] [Related]
2. Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non-small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination.
Liu B; Liu L; Hu M; Qian K; Li Y
Thorac Cancer; 2016 Sep; 7(5):549-555. PubMed ID: 27766779
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography-guided percutaneous cryoablation and microwave ablation in the treatment of perivascular hepatocellular carcinoma: A comparative study with propensity score matching.
Li B; Ren ZW; Zhang C; Yu XX; Xu XX; Du Y; Yang HF
Clin Res Hepatol Gastroenterol; 2024 Mar; 48(3):102298. PubMed ID: 38367802
[TBL] [Abstract][Full Text] [Related]
4. CT-guided percutaneous minimally invasive radiofrequency ablation for the relief of cancer related pain from metastatic non-small cell lung cancer patients: a retrospective study.
Zhou X; Li H; Qiao Q; Pan H; Fang Y
Ann Palliat Med; 2021 Feb; 10(2):1494-1502. PubMed ID: 33302633
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
6. [CT Guided Radiofrequency Ablation Followed Intratumoral Chemotherapy
in the Treatment of Early Stage Non-small Cell Lung Cancer].
Feng W; Li J; Han S; Tang J; Yao J; Cui Y; Wang C; Chen Z; Li X; Zhi X
Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):269-78. PubMed ID: 27215455
[TBL] [Abstract][Full Text] [Related]
7. [Differential population screening and efficacy analysis of (125)I implantation after radiofrequency ablation of primary liver cancer].
Ying XH; Zhang DK; Chen L; Wu FZ; Lai LQ; Song JJ; Weng QY; Tu JF; Ji JS
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1310-1314. PubMed ID: 32375438
[No Abstract] [Full Text] [Related]
8. Treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study.
Liu B; Mo C; Wang W; Ye J; Jiang C; Xie X; Huang J; Huang G; Long H; Xie X
J Endocrinol Invest; 2020 Sep; 43(9):1249-1257. PubMed ID: 32166699
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of systemic chemotherapy combined with radiofrequency ablation and microwave ablation for lung cancer: a comparative study.
Xu F; Song J; Lu Y; Wang J; Wang J; Xiao H; Li Z
Int J Hyperthermia; 2021; 38(1):900-906. PubMed ID: 34148500
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease.
Tselikas L; Garzelli L; Mercier O; Auperin A; Lamrani L; Deschamps F; Yevich S; Roux C; Mussot S; Delpla A; Varin F; Hakime A; Teriitehau C; Le Péchoux C; Pradère P; Caramella C; Besse B; Fadel E; de Baere T
Diagn Interv Imaging; 2021 Jan; 102(1):19-26. PubMed ID: 33020025
[TBL] [Abstract][Full Text] [Related]
12. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Ablation of Metastatic Lymph Nodes: An Insight from the Comparison of Efficacy and Safety Between Cryoablation and Radiofrequency Ablation.
Filippiadis DK; Pua U; Georgiadi E; Quek LHH; Kelekis A; How GY; Kelekis N
Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1134-1140. PubMed ID: 35680674
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Dual-Switching Monopolar Radiofrequency Ablation Using a Separable Clustered Electrode: A Preliminary Study.
Choi TW; Lee JM; Lee DH; Lee JH; Yu SJ; Kim YJ; Yoon JH; Han JK
Korean J Radiol; 2017; 18(5):799-808. PubMed ID: 28860897
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of radiofrequency ablation versus cryoablation in the treatment of single hepatocellular carcinoma: A population-based study.
Chen L; Ren Y; Sun T; Cao Y; Yan L; Zhang W; Ouyang T; Zheng C
Cancer Med; 2021 Jun; 10(11):3715-3725. PubMed ID: 33960697
[TBL] [Abstract][Full Text] [Related]
16. Cryoablation is superior to radiofrequency ablation for the treatment of non-small cell lung cancer: A meta-analysis.
Xu Z; Wang X; Ke H; Lyu G
Cryobiology; 2023 Sep; 112():104560. PubMed ID: 37499964
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K
Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy.
Chen J; Lin Z; Lin Q; Lin R; Yan Y; Chen J
Int J Hyperthermia; 2020; 37(1):192-201. PubMed ID: 32066293
[No Abstract] [Full Text] [Related]
19. Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
Gupta P; Maralakunte M; Kumar-M P; Chandel K; Chaluvashetty SB; Bhujade H; Kalra N; Sandhu MS
Eur Radiol; 2021 Jul; 31(7):5400-5408. PubMed ID: 33439319
[TBL] [Abstract][Full Text] [Related]
20. Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome.
Kim JH; Lee JY; Yu SJ; Lee DH; Joo I; Yoon JH; Kim YJ; Yoon JH; Lee JM
Int J Hyperthermia; 2023; 40(1):2213424. PubMed ID: 37253458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
